Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 200

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 12
Chunk 200
---
Note 12 – Fair Value Measurements 

For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2024 Form 10-K.

A.Financial Assets and Financial Liabilities Carried at Fair Value

The following table provides information about the Company's investment and derivative financial assets and liabilities carried at fair value on a recurring basis. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements in the Company's 2024 Form 10-K. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders.(In millions)Quoted Prices in Active Markets for Identical Assets(Level 1)Significant Other Observable Inputs(Level 2)Significant Unobservable Inputs(Level 3)TotalSeptember 30,2025December 31, 2024September 30,2025December 31, 2024September 30,2025December 31, 2024September 30,2025December 31, 2024Financial assets at fair valueDebt securitiesFederal government and agency$105 $165 $121 $116 $— $— $226 $281 State and local government— — 25 37 — — 25 37 Foreign government— — 412 344 — — 412 344 Corporate— — 7,130 8,049 313 374 7,443 8,423 Mortgage and other asset-backed— — 207 295 38 43 245 338 Total debt securities105 165 7,895 8,841 351 417 8,351 9,423 Equity securities (1)76 1 46 36 12 — 134 37 Short-term investments— — 276 170 — — 276 170 Derivative assets— — 74 168 936 — 1,010 168 Financial liabilities at fair valueDerivative liabilities$— $— $20 $1 $320 $— $340 $1 (1)Excludes certain equity securities